Monogenic human obesity

Frontiers of Hormone Research

Volumn 36, Issue , 2007, Pages 1-11

  Farooqi, I ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; LEPTIN; LEPTIN RECEPTOR; LEPTIN RECEPTOR, HUMAN; MC4R PROTEIN, HUMAN; MELANOCORTIN 4 RECEPTOR; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; RECOMBINANT PROTEIN;

BODY WEIGHT; CHILD; GENETICS; HUMAN; MUTATION; OBESITY; PHENOTYPE; PRESCHOOL CHILD; REVIEW;

BODY WEIGHT; CHILD; CHILD, PRESCHOOL; HUMANS; LEPTIN; MUTATION; OBESITY; PHENOTYPE; PRO-OPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTOR, TRKB; RECEPTORS, LEPTIN; RECOMBINANT PROTEINS;

EID: 43049130474     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000115333     Document Type: Review

References (44)

1. Maes HH, Neale MC, Eaves LJ: Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 1997;27:325-351.
2. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE: The body-mass index of twins who have been reared apart. N Engl J Med 1990;322:1483-1487.
3. Barsh GS, Farooqi IS, O'Rahilly S: Genetics of bodyweight regulation. Nature 2000;404:644-651.
4. Farooqi IS, O'Rahilly S: Monogenic obesity in humans. Annu Rev Med 2005;56:44x3-458.
5. Montague CT, Farooqi IS, Whitehead JP, et al: Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387: 903-908.
6. Farooqi IS, Matarese G, Lord GM, et al: Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest 2002;110:1093-1103.
7. Gibson WT, Farooqi IS, Moreau M, et al: Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab 2004;89:4821-4826.
8. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD: A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 1998;18:213-215.
9. Clement K, Vaisse C, Lahlou N, et al: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
10. Lahlou N, Landais P, De Boissieu D, Bougneres PF: Circulating leptin in normal children and during the dynamic phase of juvenile obesity: relation to body fatness, energy metabolism, caloric intake, and sexual dimorphism. Diabetes 1997;46:989-993.
11. Farooqi IS, Wangensteen T, Collins S, et al: Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med 2007;356:237-247.
12. Farooqi IS, Jebb SA, Langmack G, et al: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341: 879-884.
13. Ozata M, Ozdemir IC, Licinio J: Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84:3686-3695.
14. Mantzoros CS, Ozata M, Negrao AB, et al: Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001;86:3284-3291.
15. Licinio J, Caglayan S, Ozata M, et al: Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci USA 2004;101:4531-4536.
16. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A: Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 1998;19:155-157.
17. Farooqi IS, Drop S, Clements A, et al: Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes 2006;55:2549-2553.
18. Krude H, Biebermann H, Schnabel D, et al: Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10. J Clin Endocrinol Metab 2003;88:4633-4640.
19. Challis BG, Pritchard LE, Creemers JW, et al: A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet 2002;11:1997-2004.
20. Lee YS, Challis BG, Thompson DA, et al: A POMC variant implicates beta-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab 2006;3:135-140.
21. Biebermann H, Castaneda TR, van Landeghem F, et al: A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab 2006;3:141-146.
22. Seidah NG, Chretien M: Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 1999;848:45-62.
23. O'Rahilly S, Gray H, Humphreys PJ, et al: Brief report: impaired processing of prohormones associated with abnormalities of glucose homeostasis and adrenal function. N Engl J Med 1995;333:1386-1390.
24. Jackson RS, Creemers JW, Ohagi S, et al: Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene [see comments]. Nat Genet 1997;16:303-306.
25. Jackson RS, Creemers JW, Farooqi IS, et al: Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest 2003;112:1550-1560.
26. Yeo GS, Farooqi IS, Aminian S, Halsall DJ, Stanhope RG, O'Rahilly S: A frameshift mutation in MC4R associated with dominantly inherited human obesity [letter]. Nat Genet 1998;20:111-112.
27. Vaisse C, Clement K, Guy-Grand B, Froguel P: A frame-shift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998;20: 113-114.
28. Farooqi IS, Yeo GS, Keogh JM, et al: Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest 2000;106:271-279.
29. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P: Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest 2000;106:253-262.
30. Hinney A, Schmidt A, Nottebom K, et al: Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999;84:1483-1486.
31. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S: Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003;348:1085-1095.
32. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O: Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab 2005;90:219-224.
33. Alharbi KK, Spanakis E, Tan K, et al: Prevalence and functionality of paucimorphic and private MC4R mutations in a large, unselected European British population, scanned by meltMADGE. Hum Mutat 2007;28:294-302.
34. Huszar D, Lynch CA, Fairchild-Huntress V, et al: Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997;88:131-141.
35. Fan W, Dinulescu DM, Butler AA, Zhou J, Marks DL, Cone RD: The central melanocortin system can directly regulate serum insulin levels. Endocrinology 2000;141:3072-3079.
36. Yeo GS, Lank EJ, Farooqi IS, Keogh J, Challis BG, O'Rahilly S: Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms. Hum Mol Genet 2003;12: 561-574.
37. Lubrano-Berthelier C, Durand E, Dubern B, et al: Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations. Hum Mol Genet 2003;12:145-153.
38. Nargund RP, Strack AM, Fong TM: Melanocortin-4 receptor (MC4R) agonists for the treatment of obesity. J Med Chem 2006;49:4035-4043.
39. Bouret SG, Draper SJ, Simerly RB: Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004;304:108-110.
40. Pinto S, Roseberry AG, Liu H, et al: Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004;304:110-115.
41. Xu B, Goulding EH, Zang K, et al: Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 2003;6:736-742.
42. Snider WD: Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 1994;77:627-638.
43. Yeo GS, Connie Hung CC, Rochford J, et al: A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 2004;7:1187-1189.
44. Gray J, Yeo GS, Cox JJ, et al: Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes 2006;55:3366-3371.